Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.28 -1.7%
EPS Growth %: -27.8%
Financial Fact:
INCOME (LOSS) FROM OPERATIONS: 2.44K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -27.8%
Financial Fact:
INCOME (LOSS) FROM OPERATIONS: 2.44K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($1.26), $0.11 worse than the analyst estimate of ($1.15).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Smithfield Foods cuts Q3 outlook on fresh pork and hog price pressure
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
